NVIDIA
NVDA
Tesla
TSLA
Taiwan Semiconductor
TSM
4
Palantir
PLTR
5
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
VERA Vera Therapeutics
- 28.410
- -1.520-5.08%
Close Mar 3 16:00 ET
- 28.120
- -0.290-1.02%
Pre 08:36 ET
1.81BMarket Cap-10.33P/E (TTM)
30.555High28.260Low789.81KVolume29.990Open29.930Pre Close22.76MTurnover1.56%Turnover RatioLossP/E (Static)63.75MShares51.61052wk High3.14P/B1.44BFloat Cap25.99052wk Low--Dividend TTM50.54MShs Float51.610Historical High--Div YieldTTM7.67%Amplitude5.200Historical Low28.817Avg Price1Lot Size
Vera Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -46.10%-134.68M | -55.83%-39.18M | -60.56%-36.89M | -39.44%-24.78M | -28.67%-33.83M | -36.37%-92.18M | -18.82%-25.14M | -24.72%-22.97M | 6.63%-17.77M | -192.75%-26.29M |
| Net income from continuing operations | -58.50%-152.15M | -69.27%-43.43M | -131.95%-46.63M | -67.19%-33.71M | 5.61%-28.38M | -7.79%-95.99M | 20.91%-25.66M | 18.54%-20.1M | -35.74%-20.16M | -76.00%-30.07M |
| Depreciation and amortization | 400.00%105K | 1,275.00%55K | 300.00%24K | 189.17%1.5M | -190.32%-1.47M | 102.48%21K | 100.67%4K | 103.95%6K | 587.74%517K | -5,722.22%-506K |
| Other non cash items | 12.71%2.87M | 22.20%765K | 11.94%703K | 23.99%889K | -10.71%517K | -56.51%2.55M | 19.01%626K | -85.13%628K | 30.13%717K | 2.66%579K |
| Change In working capital | 145.69%2.66M | 64.92%-728K | 219.68%5.86M | 5,242.61%6.14M | -931.15%-8.62M | -186.29%-5.82M | -124.31%-2.08M | -953.55%-4.9M | 101.60%115K | -82.33%1.04M |
| -Change in prepaid assets | 467.05%981K | -38.69%496K | 11.69%-1.84M | 218.36%2.72M | -110.46%-392K | 102.11%173K | 267.84%809K | -1,255.19%-2.09M | 36.24%-2.3M | 195.10%3.75M |
| -Change in payables and accrued expense | 220.95%3.74M | 68.52%-704K | 468.51%8M | 20.49%4.03M | -274.70%-7.6M | -117.50%-3.09M | -122.99%-2.24M | -640.30%-2.17M | 226.34%3.35M | -119.95%-2.03M |
| -Change in other current assets | 233.97%351K | 800.00%9K | 2,809.09%320K | 104.81%13K | 325.00%9K | -136.04%-262K | 107.69%1K | 116.67%11K | 10.89%-270K | -101.48%-4K |
| -Change in other current liabilities | 9.00%-2.41M | 18.49%-529K | 5.07%-618K | 6.32%-623K | 6.32%-637K | -1.65%-2.65M | 6.35%-649K | -0.62%-651K | -4.56%-665K | -8.63%-680K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -46.10%-134.68M | -55.83%-39.18M | -60.56%-36.89M | -39.44%-24.78M | -28.67%-33.83M | -36.37%-92.18M | -18.82%-25.14M | -24.72%-22.97M | 6.63%-17.77M | -192.75%-26.29M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -977.91%-425.03M | -1,293.05%-221.38M | 136.12%38.32M | 73.77%-22.68M | -1,892.43%-219.29M | 44.11%-39.43M | 38.10%18.56M | 765.08%16.23M | -105.37%-86.45M | 131.01%12.23M |
| Net PPE purchase and sale | -1,442.86%-972K | -923.81%-645K | ---238K | ---- | ---- | -1.61%-63K | ---63K | --0 | ---- | ---- |
| Net investment purchase and sale | -977.16%-424.06M | -1,285.55%-220.74M | 137.58%38.56M | 73.87%-22.59M | -1,892.43%-219.29M | 44.15%-39.37M | 38.57%18.62M | 775.60%16.23M | -105.40%-86.45M | 131.02%12.23M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -977.91%-425.03M | -1,293.05%-221.38M | 136.12%38.32M | 73.77%-22.68M | -1,892.43%-219.29M | 44.11%-39.43M | 38.10%18.56M | 765.08%16.23M | -105.37%-86.45M | 131.01%12.23M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 354.30%606.67M | 1,212.85%325.96M | 148.82%739K | 696.06%3.44M | 156.09%276.54M | 31.01%133.54M | 19.89%24.83M | -67.29%297K | 800.00%432K | 34.53%107.98M |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | 24.85%24.74M | ---- | ---- | ---- | ---- |
| Net common stock issuance | 450.02%632.52M | --345M | ---13K | --0 | 150.03%287.54M | 33.52%115M | --0 | --0 | --0 | 33.52%115M |
| Proceeds from stock option exercised by employees | 1,170.17%13.41M | 2,556.32%2.31M | 153.20%752K | 696.06%3.44M | 2,779.58%6.91M | -49.30%1.06M | -89.48%87K | -69.54%297K | 819.15%432K | 2.56%240K |
| Net other financing activities | -441.12%-39.26M | ---21.36M | --0 | --0 | -146.80%-17.91M | -19.01%-7.26M | --0 | --0 | --0 | -19.03%-7.26M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 354.30%606.67M | 1,212.85%325.96M | 148.82%739K | 696.06%3.44M | 156.09%276.54M | 31.01%133.54M | 19.89%24.83M | -67.29%297K | 800.00%432K | 34.53%107.98M |
| Net cash flow | ||||||||||
| Beginning cash position | 4.41%45.68M | -0.67%27.26M | -25.98%25.09M | -49.81%69.11M | 4.41%45.68M | -45.29%43.75M | -10.81%27.44M | -33.18%33.89M | 23.15%137.68M | -45.29%43.75M |
| Current changes in cash | 2,334.68%46.97M | 258.50%65.39M | 133.67%2.17M | 57.59%-44.02M | -75.06%23.42M | 105.33%1.93M | 40.48%18.24M | 67.68%-6.45M | -69.93%-103.79M | 195.07%93.93M |
| End cash Position | 102.81%92.65M | 102.81%92.65M | -0.67%27.26M | -25.98%25.09M | -49.81%69.11M | 4.41%45.68M | 4.41%45.68M | -10.81%27.44M | -33.18%33.89M | 23.15%137.68M |
| Free cash flow | -47.06%-135.65M | -58.00%-39.83M | -61.59%-37.12M | -39.94%-24.87M | -28.67%-33.83M | -36.34%-92.24M | -19.11%-25.21M | -24.46%-22.97M | 6.65%-17.77M | -192.17%-26.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |